Results
|
1481.
|
|
|
1482.
|
|
|
1483.
|
E4F1 is a master regulator of CHK1-mediated functions. [electronic resource] by
- Grote, David
- Moison, Céline
- Duhamel, Stéphanie
- Chagraoui, Jalila
- Girard, Simon
- Yang, Jay
- Mayotte, Nadine
- Coulombe, Yan
- Masson, Jean-Yves
- Brown, Grant W
- Meloche, Sylvain
- Sauvageau, Guy
Producer: 20160108
In:
Cell reports vol. 11
Availability: No items available.
|
|
1484.
|
Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells. [electronic resource] by
- Chen, Sansan
- Chen, Xinglu
- Xie, Gui'e
- He, Yue
- Yan, Daoyu
- Zheng, Dianpeng
- Li, Shi
- Fu, Xinyang
- Li, Yeping
- Pang, Xiang
- Hu, Zhiming
- Li, Hongwei
- Tan, Wanlong
- Li, Jinlong
Producer: 20180117
In:
Oncotarget vol. 7
Availability: No items available.
|
|
1485.
|
|
|
1486.
|
Long noncoding RNA LINC02582 acts downstream of miR-200c to promote radioresistance through CHK1 in breast cancer cells. [electronic resource] by
- Wang, Baiyao
- Zheng, Jieling
- Li, Rong
- Tian, Yunhong
- Lin, Jie
- Liang, Yingying
- Sun, Quanquan
- Xu, Anan
- Zheng, Ronghui
- Liu, Mengzhong
- Ji, Aimin
- Bu, Junguo
- Yuan, Yawei
Producer: 20200827
In:
Cell death & disease vol. 10
Availability: No items available.
|
|
1487.
|
|
|
1488.
|
|
|
1489.
|
|
|
1490.
|
|
|
1491.
|
|
|
1492.
|
|
|
1493.
|
|
|
1494.
|
|
|
1495.
|
The preclinical pharmacology and therapeutic activity of the novel CHK1 inhibitor SAR-020106. [electronic resource] by
- Walton, Michael I
- Eve, Paul D
- Hayes, Angela
- Valenti, Melanie
- De Haven Brandon, Alexis
- Box, Gary
- Boxall, Kathy J
- Aherne, G Wynne
- Eccles, Suzanne A
- Raynaud, Florence I
- Williams, David H
- Reader, John C
- Collins, Ian
- Garrett, Michelle D
Producer: 20100322
In:
Molecular cancer therapeutics vol. 9
Availability: No items available.
|
|
1496.
|
|
|
1497.
|
|
|
1498.
|
|
|
1499.
|
|
|
1500.
|
|